Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-016718
Filing Date
2004-03-19
Accepted
2004-03-19 16:52:24
Documents
1
Period of Report
2004-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6331
  Complete submission text file 0001209191-04-016718.txt   8387
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BIOCRYST PHARMACEUTICALS, INC 2190 PKWY LAKE DRIVE BIRMINGHAM AL 35244
Business Address C/O BIOCRYST PHARMACEUTICALS, INC 2190 PKWY LAKE DRIVE BIRMINGHAM AL 35244 2054444600
GEE EDWIN A (Reporting) CIK: 0001198760 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 04680506